Latest & greatest articles for cephalosporin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cephalosporin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cephalosporin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cephalosporin

1. Ceftazidime + avibactam (Zavicefta). An option in the case of cephalosporin resistance

Ceftazidime + avibactam (Zavicefta). An option in the case of cephalosporin resistance Prescrire IN ENGLISH - Spotlight ''Ceftazidime + avibactam (Zavicefta°). An option in the case of cephalosporin resistance'', 1 March 2018 {1} {1} {1} | | > > > Ceftazidime + avibactam (Zavicefta°). An option in the case of cephalosporin resistance Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |  (...)  |   |  Spotlight Ceftazidime + avibactam (Zavicefta°). An option in the case of cephalosporin resistance FEATURED REVIEW A ceftazidime + avibactam combination (Zavicefta°, Pfizer) has been approved in the European Union for the treatment of various “complicated” infections. In one clinical trial, the combination was as effective as a carbapenem and had an acceptable adverse effect profile. Full review (2 pages) available for download by subscribers. In practice The ceftazidime

2018 Prescrire

2. Comparative proteomics analysis of Neisseria gonorrhoeae strains in response to extended-spectrum cephalosporins Full Text available with Trip Pro

Comparative proteomics analysis of Neisseria gonorrhoeae strains in response to extended-spectrum cephalosporins Neisseria gonorrhoeae strains displaying reduced susceptibility and resistance to extended-spectrum cephalosporins (ESCs) are major public health concerns. Although resistance mechanisms of ESCs have extensively been studied, the proteome-wide investigation on the biological response to the antibiotic stress is still limited. Herein, a proteomics approach based on two-dimensional gel

2017 EXCLI journal

3. ZAVICEFTA, (ceftazidime/avibactam), cephalosporin and ?-lactamase inhibitor

ZAVICEFTA, (ceftazidime/avibactam), cephalosporin and ?-lactamase inhibitor Haute Autorité de Santé - ZAVICEFTA, (ceftazidime/avibactam), céphalosporine et inhibiteur de βlactamase Développer la qualité dans le champ sanitaire, social et médico-social Recherche Évaluation & Recommandation La HAS Accréditation & Certification Outils, Guides & Méthodes Agenda Avis sur les Médicaments ZAVICEFTA, (ceftazidime/avibactam), céphalosporine et inhibiteur de βlactamase Substance active (DCI) avibactam

2016 Haute Autorite de sante

4. Cephalosporins

Cephalosporins USE OF CEPHALOSPORINS IN PREGNANCY 0344 892 0909 USE OF CEPHALOSPORINS IN PREGNANCY (Date of issue: June 2017 , Version: 3.1 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary The cephalosporins (commonly used include: cefaclor (...) , cefadroxil, cefalexin, cefixime, cefotaxime, cefpodoxime, cefradine, ceftazidime, ceftriaxone and cefuroxime) are a class of β-lactam antibiotics originally derived from the Acremonium fungus. Cephalosporins are broad-spectrum antibacterial agents used in the treatment of respiratory tract infections, otitis media, skin and soft tissue infections, urinary tract infections, sexually transmitted infections, septicaemia, meningitis, peritonitis, endocarditis, and in the prophylaxis of postoperative

2014 UK Teratology Information Service

5. Anaphylactic Cross-Reactivity Between Penicillin and Cephalosporin

Anaphylactic Cross-Reactivity Between Penicillin and Cephalosporin UTCAT848, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Minimal Risk Of Severe Type 1 Hypersensitivity Reaction To Third Generation Cephalosporin In Patients Who Experience Type 1 Hypersensitivity Reaction And Allergy To Penicillin Clinical Question Do patients who experience a severe type 1 hypersensitivity reaction to penicillin and demonstrate (...) an allergy to cephalosporin experience a severe type 1 hypersensitivity reaction to the cephalosporin? Clinical Bottom Line It appears that patients who have a severe type 1 hypersensitivity reaction to penicillin do not have an increased risk of anaphylaxis to cephalosporins. This evidence may be skewed however by adherence to the recommendation not to give cephalosporins to individuals with a history of penicillin anaphylaxis. (See Comments on the CAT below) Best Evidence (you may view more info

2011 UTHSCSA Dental School CAT Library

6. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. (Abstract)

Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. In patients with documented IgE-mediated hypersensitivity to penicillins, data on sensitization to cephalosporins vary. Administering cephalosporins to such patients is often deferred because of the risk for cross-reactivity.To assess the cross-reactivity with cephalosporins and its potential determinants in patients with documented penicillin allergy.Prospective study in patients (...) without clinical indications for cephalosporin treatment.Italy.128 consecutive patients who sustained anaphylactic shock (n = 81) or urticaria (n = 47) and had positive results on skin tests for at least 1 of the penicillin reagents tested.All patients were skin tested with cephalothin, cefamandole, cefuroxime, ceftazidime, ceftriaxone, and cefotaxime. Patients with negative results for the last 4 cephalosporins were challenged with cefuroxime axetil and ceftriaxone.14 patients (10.9% [95% CI, 6.1

2004 Annals of Internal Medicine

7. Ceftriaxone versus other cephalosporins for perioperative antibiotic prophylaxis: a meta-analysis of 43 randomized controlled trials

Ceftriaxone versus other cephalosporins for perioperative antibiotic prophylaxis: a meta-analysis of 43 randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.

8. Antibiotic therapy for acute appendicitis: Ampicillin, metronidazole plus gentamycin versus cephalosporin

Antibiotic therapy for acute appendicitis: Ampicillin, metronidazole plus gentamycin versus cephalosporin Antibiotic therapy for acute appendicitis: Ampicillin, metronidazole plus gentamycin versus cephalosporin Antibiotic therapy for acute appendicitis: Ampicillin, metronidazole plus gentamycin versus cephalosporin Muggli E Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation Muggli E. Antibiotic therapy for acute appendicitis: Ampicillin, metronidazole plus gentamycin versus cephalosporin. Clayton, Victoria: Centre for Clinical Effectiveness (CCE) 2002: 12 Authors' objectives This aim of this report was to assess which antibiotic regimen is more appropriate for acute appendicitis: Ampicillin, metronidazole plus gentamycin or cephalosporin (+/- metronidazole). Authors' conclusions - One randomised trial was reviewed that met inclusion and exclusion criteria

2002 Health Technology Assessment (HTA) Database.

9. Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy for the treatment of febrile episodes in neutropenic patients

Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy for the treatment of febrile episodes in neutropenic patients Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy for the treatment of febrile episodes in neutropenic patients Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy for the treatment of febrile episodes in neutropenic patients (...) Paladino J A, Fong D A, Forrest A, Ramphal R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy for the treatment of febrile episodes in neutropenic

2000 NHS Economic Evaluation Database.

10. Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast surgery: a randomized double-blind trial involving 1,766 patients

Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast surgery: a randomized double-blind trial involving 1,766 patients Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

1999 NHS Economic Evaluation Database.

11. Ceftibuten: a new expanded-spectrum oral cephalosporin

Ceftibuten: a new expanded-spectrum oral cephalosporin Ceftibuten: a new expanded-spectrum oral cephalosporin Ceftibuten: a new expanded-spectrum oral cephalosporin Guay D R Authors' objectives To review the antimicrobial activity, pharmacokinetics, clinical efficacy, and tolerability of ceftibuten, a new expanded-spectrum oral cephalosporin. Searching Literature was identified by searching MEDLINE from January 1983 to June 1996, through a review of English-language literature, by examining (...) ceftibuten and other antimicrobial agents are needed to firmly establish its place in therapy. CRD commentary The methods used to search the literature, the inclusion criteria, and details of the studies were presented in the review. Study quality was not assessed. The author's conclusions seem appropriate. Bibliographic details Guay D R. Ceftibuten: a new expanded-spectrum oral cephalosporin. Annals of Pharmacotherapy 1997; 31(9): 1022-1033 PubMedID Indexing Status Subject indexing assigned by NLM MeSH

1997 DARE.